You just read:

Medical Marijuana, Inc Major Investment AXIM Biotech Enters Agreement With Israel-Based CRO To Begin Clinical POC Study For Treatment Of Restless Leg Syndrome

News provided by

Medical Marijuana, Inc.

Jul 27, 2017, 09:00 ET